These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. [Pharmacology in the elderly. Changes in the pharmacodynamic response to a given drug concentration and changes in mechanisms of regulation]. Jolliet P; Barré J; Hamon B; Piette F; Tillement JP Ann Med Interne (Paris); 1995; 146(5):328-34. PubMed ID: 8526320 [No Abstract] [Full Text] [Related]
49. Quantitative structure-pharmacokinetic/pharmacodynamic relationships. Mager DE Adv Drug Deliv Rev; 2006 Nov; 58(12-13):1326-56. PubMed ID: 17092600 [TBL] [Abstract][Full Text] [Related]
50. [The effect of chirality in clinical pharmacology]. Le Corre P; Sado P; Le Verge R J Pharm Belg; 1991; 46(5):331-47. PubMed ID: 1791526 [TBL] [Abstract][Full Text] [Related]
51. [Drug incompatibility in the aged]. Platt D Fortschr Med; 1983 Sep; 101(33):1449-54. PubMed ID: 6629269 [TBL] [Abstract][Full Text] [Related]
52. [Drug therapy for the elderly]. Platt D; Mühlberg W Internist (Berl); 1994 Oct; 35(10):955-78. PubMed ID: 8002235 [No Abstract] [Full Text] [Related]
53. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Mangoni AA; Jackson SH Br J Clin Pharmacol; 2004 Jan; 57(1):6-14. PubMed ID: 14678335 [TBL] [Abstract][Full Text] [Related]
54. Insights into mesenchymal stem cell aging: involvement of antioxidant defense and actin cytoskeleton. Kasper G; Mao L; Geissler S; Draycheva A; Trippens J; Kühnisch J; Tschirschmann M; Kaspar K; Perka C; Duda GN; Klose J Stem Cells; 2009 Jun; 27(6):1288-97. PubMed ID: 19492299 [TBL] [Abstract][Full Text] [Related]
55. Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence. Caron M; Auclair M; Donadille B; Béréziat V; Guerci B; Laville M; Narbonne H; Bodemer C; Lascols O; Capeau J; Vigouroux C Cell Death Differ; 2007 Oct; 14(10):1759-67. PubMed ID: 17612587 [TBL] [Abstract][Full Text] [Related]
56. [Differences in pharmacokinetic and pharmacodynamic processes in elderly patients]. Herman ZS Pol Arch Med Wewn; 1989 Jul; 82(1):30-40. PubMed ID: 2638738 [No Abstract] [Full Text] [Related]
57. The role of mitochondria in ageing and carcinogenesis. Birch-Machin MA Clin Exp Dermatol; 2006 Jul; 31(4):548-52. PubMed ID: 16716161 [TBL] [Abstract][Full Text] [Related]
58. [Drug therapy in the elderly]. Ishizaki T Nihon Ronen Igakkai Zasshi; 1992 Jan; 29(1):10-6. PubMed ID: 1560603 [TBL] [Abstract][Full Text] [Related]
59. Factors affecting antiepileptic drug pharmacokinetics in community-dwelling elderly. Cloyd JC; Marino S; Birnbaum AK Int Rev Neurobiol; 2007; 81():201-10. PubMed ID: 17433925 [TBL] [Abstract][Full Text] [Related]
60. Drug therapy in dental practice: general principles. Part 1 - Pharmacokinetic considerations. Becker DE Anesth Prog; 2006; 53(4):140-5; quiz 146. PubMed ID: 17177593 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]